AA
accounts advised by T. Rowe Price
accounts advised by T. Rowe Price is a Series A to Series D stage investment firm. It has made 5 investments. Average disclosed round size is $125.7M (across 5 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
CT
Chuck Turgeon
CFA
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| HHarvey AI Corporation | Series B | $200M | Jan 2025 |
| SSionna | Series C | $182M | Jan 2024 |
| 11stdibs.com | Series D | $76M | Mar 2019 |
| OObsidian Therapeutics, Inc. | Series A | $160.5M | — |
| AApiture | Unknown | $10M | — |
Top Co-Investors
Atlas Venture2 shared
Viking Global Investors1 shared
Cystic Fibrosis Foundation1 shared
OrbiMed1 shared
Enavate Sciences1 shared
Perceptive Advisors1 shared
Blue Owl Healthcare Opportunities1 shared
Wellington Management1 shared
Vertex Ventures HC1 shared
Alexandria Venture Investments1 shared
Logos Capital1 shared
Bristol Myers Squibb1 shared
Surveyor Capital1 shared
Deep Track Capital1 shared
Amgen Ventures1 shared
Samsara BioCapital1 shared
Takeda Ventures, Inc.1 shared
Foresite Capital1 shared
Novo Holdings A/S1 shared
RA Capital Management1 shared
Last updated: 14 September 2026